Advanced Cell Technology, Inc. (ACTC) - Financial and Strategic SWOT Analysis Review

Date: April 22, 2014
Pages: 40
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A4BB5ACEF5CEN
Leaflet:

Download PDF Leaflet

Advanced Cell Technology, Inc. (ACTC) - Financial and Strategic SWOT Analysis Review
Advanced Cell Technology, Inc. (ACTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Advanced Cell Technology, Inc. (ACT) is a biotechnology company, specializes in regenerative medicine. The company participates in the development of cellular therapies for the treatment of diseases. Currently, ACT conducts the human embryonic stem cell (hESC)-based human clinical trials in the US and Europe. The two US trials use retinal pigment epithelial (RPE) cells derived from hESCs treats forms of macular degeneration, including Dry Age-Related Macular Degeneration (Dry AMD), the leading cause of blindness.

Advanced Cell Technology, Inc. Key Recent Developments

Mar 24, 2014: New Mesenchymal Stem Cell Population from Human Pluripotent Stem Cells Displays Potent Immunomodulatory and Therapeutic Properties
Jan 22, 2014: Advanced Cell Technology Announces Change in Management
Dec 18, 2013: Advanced Cell Technology Announces Release of New Edition of Definitive Resource in Tissue Engineering
Dec 12, 2013: Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
Nov 12, 2013: Advanced Cell Technology Announces 2013 Third Quarter Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Advanced Cell Technology, Inc. - Key Facts
Advanced Cell Technology, Inc. - Key Employees
Advanced Cell Technology, Inc. - Key Employee Biographies
Advanced Cell Technology, Inc. - Major Products and Services
Advanced Cell Technology, Inc. - Pharmaceutical Pipeline Products Data
Advanced Cell Technology, Inc., Pipeline Products by Therapy Area
Advanced Cell Technology, Inc., Pipeline Products by Development Phase
Advanced Cell Technology, Inc. - History
Advanced Cell Technology, Inc. - Company Statement
Advanced Cell Technology, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Advanced Cell Technology, Inc. - Business Description
Advanced Cell Technology, Inc. - SWOT Analysis
SWOT Analysis - Overview
Advanced Cell Technology, Inc. - Strengths
Strength - Focused Research Expertise
Strength - Patent Portfolio: Intellectual Property
Strength - Strategic Collaborative Agreements
Advanced Cell Technology, Inc. - Weaknesses
Weakness - Involvement in Legal Proceedings
Weakness - History of Losses
Advanced Cell Technology, Inc. - Opportunities
Opportunity - Rising Geriatric Population
Opportunity - Market Potential: Age-related Macular Degeneration
Opportunity - Potential Market: Cardiovascular/ Heart Failure
Advanced Cell Technology, Inc. - Threats
Threat - Dependence on Emerging Technologies
Threat - Uncertain R&D Outcomes
Threat - Increasing Competitive Pressures
Advanced Cell Technology, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Advanced Cell Technology, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Advanced Cell Technology, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Advanced Cell Technology, Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Advanced Cell Technology, Inc., Recent Developments
Mar 24, 2014: New Mesenchymal Stem Cell Population from Human Pluripotent Stem Cells Displays Potent Immunomodulatory and Therapeutic Properties
Jan 22, 2014: Advanced Cell Technology Announces Change in Management
Dec 18, 2013: Advanced Cell Technology Announces Release of New Edition of Definitive Resource in Tissue Engineering
Dec 12, 2013: Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
Nov 12, 2013: Advanced Cell Technology Announces 2013 Third Quarter Results
Nov 11, 2013: Advanced Cell Technology to Host Conference Call to Discuss 2013 Third Quarter Results and Provide a Corporate Update on Tuesday, November 12th
Oct 18, 2013: Advanced Cell Technology to Webcast 2013 Annual Shareholders’ Meeting on Tuesday, October 22nd
Sep 25, 2013: Advance Cell Technology to Present at 2013 Aegis Capital Healthcare Conference
Aug 12, 2013: Advanced Cell Technology Files Preliminary Proxy Statement with Securities and Exchange Commission
Aug 07, 2013: Advanced Cell Technology Announces Second Quarter 2013 Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Advanced Cell Technology, Inc., Key Facts
Advanced Cell Technology, Inc., Key Employees
Advanced Cell Technology, Inc., Key Employee Biographies
Advanced Cell Technology, Inc., Major Products and Services
Advanced Cell Technology, Inc., Number of Pipeline Products by Therapy Area
Advanced Cell Technology, Inc., Number of Pipeline Products by Development Stage
Advanced Cell Technology, Inc., Pipeline Products By Therapy Area and Development Phase
Advanced Cell Technology, Inc., History
Advanced Cell Technology, Inc., Other Locations
Advanced Cell Technology, Inc., Subsidiaries
Advanced Cell Technology, Inc., Key Competitors
Advanced Cell Technology, Inc., Ratios based on current share price
Advanced Cell Technology, Inc., Annual Ratios
Advanced Cell Technology, Inc., Interim Ratios
Advanced Cell Technology, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Advanced Cell Technology, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Advanced Cell Technology, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Advanced Cell Technology, Inc., Pipeline Products by Therapy Area
Advanced Cell Technology, Inc., Pipeline Products by Development Phase
Advanced Cell Technology, Inc., Performance Chart (2009 - 2013)
Advanced Cell Technology, Inc., Ratio Charts
Advanced Cell Technology, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Advanced Cell Technology, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Skip to top


Ask Your Question

Advanced Cell Technology, Inc. (ACTC) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: